Brian Fuehrlein, MD, PhD
Associate Professor of PsychiatryCards
About
Research
Publications
2026
Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.
Blum K, Lewandrowski A, Sharafshah A, Pinhasov A, Mohankumar K, Gold M, Fuehrlein B, Elman I, Dennen C, Thanos P, Bowirrat A, Baron D, Modestino E, Jafari N, Zeine F, Sunder K, Makale M, Lorio M, Khalsa J, Schmidt S, Fiorelli R, Weinstein A, Lindenau M, Lewandrowski K, Alves Ó, Mahajan S, Mahajan Y, Badgaiyan R. Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety. Current Pharmaceutical Biotechnology 2026, 27 PMID: 41830575, DOI: 10.2174/0113892010431102260107110422.Peer-Reviewed Original ResearchEstablishing criteria for emergency department-based episode of care definitions: a modified Delphi study
Kocher K, Myers A, Urech T, Asch S, Admon A, Fuehrlein B, Gettel C, Patel N, Pines J, Potochny N, Sabbatini A, Vanneman M, Ward M, Vashi A. Establishing criteria for emergency department-based episode of care definitions: a modified Delphi study. BMJ Open 2026, 16: e111727. PMID: 41781042, PMCID: PMC12970077, DOI: 10.1136/bmjopen-2025-111727.Peer-Reviewed Original ResearchBeyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery
Blum K, Gold M, Jafari N, Lewandrowski K, Sharafshah A, Mohankumar K, Lorio M, Bowirrat A, Pinhasov A, Thanos K, Elman I, Baron D, Dennen C, Fuehrlein B, Lewandrowski A, Modestino E, Thanos P, Zeine F. Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery. Psychology Research And Behavior Management 2026, 19: 561157. PMID: 41710726, PMCID: PMC12911994, DOI: 10.2147/prbm.s561157.Peer-Reviewed Original Research
2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis
Sharafshah A, Blum K, Lewandrowski K, Elman I, Fuehrlein B, Baron D, Pinhasov A, Thanos P, Fiorelli R, Schmidt S, Gardner E, Lorio M, Lewandrowski A, Gold M. Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis. Journal Of Personalized Medicine 2025, 15: 579. PMID: 41440942, PMCID: PMC12734362, DOI: 10.3390/jpm15120579.Peer-Reviewed Original ResearchCorrection: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia
Lewandrowski K, Blum K, Lewandrowski A, Thanos P, Pinhasov A, Sharafshah A, Baron D, Gold M, Dennen C, Elman I, Bowirrat A, Modestino E, Zeine F, Jafari N, Sunder K, Makale M, Giordano J, Gondre-Lewis M, Lindenau M, Fuehrlein B, Badgaiyan R, Levin C, Schmidt S, Fiorelli R. Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. Frontiers In Public Health 2025, 13: 1737084. PMID: 41334398, PMCID: PMC12667608, DOI: 10.3389/fpubh.2025.1737084.Commentaries, Editorials and LettersTargeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia
Lewandrowski K, Blum K, Lewandrowski A, Thanos P, Pinhasov A, Sharafshah A, Baron D, Gold M, Dennen C, Elman I, Bowirrat A, Modestino E, Zeine F, Jafari N, Sunder K, Makale M, Giordano J, Gondre-Lewis M, Lindenau M, Fuehrlein B, Badgaiyan R, Levin C, Schmidt S, Fiorelli R. Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. Frontiers In Public Health 2025, 13: 1594872. PMID: 41080838, PMCID: PMC12512667, DOI: 10.3389/fpubh.2025.1594872.Peer-Reviewed Original ResearchPGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse.
Sharafshah A, Thanos P, Pinhasov A, Bowirrat A, Hanna C, Lewandrowski K, Rowan C, Elman I, Gold M, Dennen C, Modestino E, Badgaiyan R, Baron D, Fuehrlein B, Gupta A, Cadet J, Pollack A, Khalsa J, Makale M, Lewandrowski A, Blum K. PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse. Current Neuropharmacology 2025, 23 PMID: 40993956, DOI: 10.2174/011570159x390146250831143523.Peer-Reviewed Original ResearchGWAS meta-meta-analysis and related analyses revealed a shared genetic background between ADHD and narcolepsy
Modestino E, Sharafshah A, Lewandrowski K, Carey E, Mohankumar K, Thanos P, Pinhasov A, Bowirrat A, Baron D, Gold M, Elman I, Gardner E, Fuehrlein B, Zeine F, Jafari N, Dennen C, Lewandrowski A, Badgaiyan R, Blum K. GWAS meta-meta-analysis and related analyses revealed a shared genetic background between ADHD and narcolepsy. Academia Molecular Biology And Genomics 2025, 2 DOI: 10.20935/acadmolbiogen7751.Peer-Reviewed Original ResearchA Review of the Evidence Surrounding Popular Cognitive Enhancers
Draghmeh K, Elmarasi M, Fuehrlein B. A Review of the Evidence Surrounding Popular Cognitive Enhancers. Current Psychopharmacologye 2025, 13 DOI: 10.2174/0122115560363501250609121229.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMulti-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical Targeting.
Blum K, Mohankumar K, Bagchi D, Lewandrowski K, Sharafshah A, Elman I, Gold M, Dennen C, Thanos P, Pinhasov A, Bowirrat A, Lewandrowski A, Baron D, Modestino E, Fuehrlein B, Khalsa J, Gastelu D, Fliegelman C, Sunder K, Murphy K, Makale M, Madigan M, Lindenau M, Swaroop A, Badgaiyan R. Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical Targeting. EC Neurology 2025, 17 PMID: 41019658, PMCID: PMC12463428.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
Academic Achievements & Community Involvement
News
News
- June 08, 2026
Abdelnour, Burke, Hicks Graduate from YSM Education Scholars Fellowship
- November 24, 2025
Fuehrlein to Receive 2025 Pillar of Excellence Award
- December 12, 2024
Fuehrlein, Pérez Palmer, Wilkins Promoted at VA
- August 27, 2024Source: Psychology Today
Smoking Hard Drugs Is Now Killing Many Users
Get In Touch
Contacts
Mailing Address
Psychiatry
VA Connecticut Healthcare System, 950 Campbell Ave
West Haven, CT 06516
United States